Stay updated on IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine Clinical Trial
Sign up to get notified when there's something new on the IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine Clinical Trial page.

Latest updates to the IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedNew site revision label (v3.6.6) appears, replacing the previous v3.6.5. This indicates a routine system update to the page without altering study data or visible content.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe record history now shows Revision: v3.6.5 as the latest version, replacing the previous v3.6.4, indicating an update to the page's revision history display.SummaryDifference0.0%

- Check48 days agoChange DetectedThe revision history now includes the new site revision v3.6.4 and removes the prior v3.6.3, reflecting a minor maintenance update to the page's footer/versioning.SummaryDifference0.0%

- Check55 days agoChange DetectedA new Study Status entry was added to the record history on 2026-07-14, updating the trial's current status. An additional line with the value '80' was added on 2026-07-13, and an entry from 2026-06-04 was removed from the history.SummaryDifference0.2%

- Check76 days agoChange DetectedRevision: v3.6.3 appears in the page footer, replacing Revision: v3.6.0. This indicates the page was updated to a newer version.SummaryDifference0.0%

- Check91 days agoChange DetectedThe recruitment status is updated to 'no longer looking for participants,' indicating the study is not enrolling at this time. The record's revision tag was updated from v3.5.5 to v3.6.0, reflecting a new version of the study record.SummaryDifference0.2%

Stay in the know with updates to IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine Clinical Trial page.